These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9164677)
1. Mechanism of action of a tyrphostin, 3,4-dihydroxy-alpha-cyanothiocinnamamide, in breast cancer cell growth inhibition involves the suppression of cyclin B1 and the functional activity of cyclin B1/p34cdc2 complex. Faaland CA; Adhikarakunnathu S; Thomas T; Thomas TJ Breast Cancer Res Treat; 1997 May; 44(1):47-56. PubMed ID: 9164677 [TBL] [Abstract][Full Text] [Related]
2. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Ling YH; el-Naggar AK; Priebe W; Perez-Soler R Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633 [TBL] [Abstract][Full Text] [Related]
3. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole. Akiyama T; Shimizu M; Okabe M; Tamaoki T; Akinaga S Anticancer Drugs; 1999 Jan; 10(1):67-78. PubMed ID: 10194549 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity. Arita Y; Buffolino P; Coppock DL Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525 [TBL] [Abstract][Full Text] [Related]
6. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Choi YH; Zhang L; Lee WH; Park KY Int J Oncol; 1998 Aug; 13(2):391-6. PubMed ID: 9664138 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
8. 2-methoxyestradiol-induced growth suppression and lethality in estrogen-responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 expression. Zoubine MN; Weston AP; Johnson DC; Campbell DR; Banerjee SK Int J Oncol; 1999 Oct; 15(4):639-46. PubMed ID: 10493943 [TBL] [Abstract][Full Text] [Related]
10. Sustained accumulation of the mitotic cyclins and tyrosine-phosphorylated p34cdc2 in human G1-S-arrested cancer cells but not untransformed cells. David-Pfeuty T; Nouvian-Dooghe Y Cancer Res; 1997 Oct; 57(20):4482-7. PubMed ID: 9377557 [TBL] [Abstract][Full Text] [Related]
11. Cyclin b1 promoter activity and functional cdk1 complex formation in G1 phase of human breast cancer cells. Barrett KL; Demiranda D; Katula KS Cell Biol Int; 2002; 26(1):19-28. PubMed ID: 11779217 [TBL] [Abstract][Full Text] [Related]
12. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Yin F; Giuliano AE; Law RE; Van Herle AJ Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771 [TBL] [Abstract][Full Text] [Related]
13. The tryphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2. Palumbo GA; Yarom N; Gazit A; Sandalon Z; Baniyash M; Kleinberger-Doron N; Levitzki A; Ben-Yehuda D Cancer Res; 1997 Jun; 57(12):2434-9. PubMed ID: 9192822 [TBL] [Abstract][Full Text] [Related]
14. Expression of the G2-M checkpoint regulators cyclin B1 and P34CDC2 in breast cancer: a correlation with cellular kinetics. Megha T; Lazzi S; Ferrari F; Vatti R; Howard CM; Cevenini G; Leoncini L; Luzi P; Giordano A; Tosi P Anticancer Res; 1999; 19(1A):163-9. PubMed ID: 10226538 [TBL] [Abstract][Full Text] [Related]
15. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031 [TBL] [Abstract][Full Text] [Related]
16. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells. Lee AW; Nambirajan S; Moffat JG Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507 [TBL] [Abstract][Full Text] [Related]
17. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Chen WJ; Chang CY; Lin JK Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329 [TBL] [Abstract][Full Text] [Related]
18. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Foster JS; Wimalasena J Mol Endocrinol; 1996 May; 10(5):488-98. PubMed ID: 8732680 [TBL] [Abstract][Full Text] [Related]
19. Laser scanning cytometric analysis of cyclin B1 in primary human malignancies. Gorczyca W; Sarode V; Juan G; Melamed MR; Darzynkiewicz Z Mod Pathol; 1997 May; 10(5):457-62. PubMed ID: 9160310 [TBL] [Abstract][Full Text] [Related]
20. Delaying the onset of M phase in NIH 3T3 cells blocked in early S phase occurs via accumulating cyclin B1 and tyrosine-phosphorylated p34cdc2 in the nucleus. David-Pfeuty T; Nouvian-Dooghe Y; Rouillard D Biol Cell; 1997 Jun; 89(3):179-97. PubMed ID: 9429302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]